Medicare Enrolled
Dr. Paul Bierman, MD
Gastroenterology · Harvey, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bierman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bierman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bierman
Dr. Paul Bierman is a gastroenterology specialist in Harvey, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Bierman performed 2,073 Medicare services across 1,587 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bierman received a total of $58,864 from 48 pharmaceutical and/or device companies across 516 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bierman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 5% volume in IL
$58,864 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,073
Medicare services
Top 5% in IL for gastroenterology
1,587
Unique beneficiaries
$81
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~104 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
462 | $60 | $125 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
382 | $38 | $80 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
289 | $84 | $150 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
163 | $101 | $208 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
159 | $97 | $150 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
148 | $62 | $825 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
102 | $195 | $1,120 |
| Colonoscopy for colorectal cancer screening, high risk A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease. |
48 | $169 | $750 |
| Colonoscopy for colorectal cancer screening A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease. |
40 | $171 | $750 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
38 | $104 | $875 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
38 | $59 | $110 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
30 | $72 | $135 |
| Endoscopic insertion of stomach tube A flexible endoscope is used to guide the placement of a tube into the stomach. |
27 | $141 | $890 |
| Esophageal dilation with guide wire and endoscope A flexible endoscope is used to insert a guide wire into the esophagus, followed by dilation to widen the esophageal passage. |
26 | $106 | $700 |
| Colon polyp removal with endoscope and cautery This procedure removes polyps or growths from the large bowel using a flexible tube with a camera. Electrical cautery is used to stop bleeding during the removal. |
25 | $113 | $975 |
| Colonoscopy A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon. |
23 | $126 | $800 |
| Upper endoscopy (EGD) A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope. |
22 | $81 | $560 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
20 | $132 | $200 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
19 | $33 | $115 |
| Balloon dilation of esophagus, stomach, or upper small bowel, less than 3.0 cm A procedure using a flexible endoscope to widen a narrowed section of the esophagus, stomach, or upper small bowel with a balloon that is less than 3.0 cm in length. |
12 | $85 | $900 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$58,864
Total received (2018-2024)
Avg $8,409/year across 7 years
Top 7% in IL for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
516
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$52,365 (89.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,200 (10.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$300 (0.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,709
2023
$1,514
2022
$1,453
2021
$33
2020
$389
2019
$15,021
2018
$38,746
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$520
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$163
Gilead Sciences, Inc.
$156
Takeda Pharmaceuticals U.S.A., Inc.
$107
Lilly USA, LLC
$98
GENZYME CORPORATION
$92
Ardelyx, Inc.
$83
Janssen Biotech, Inc.
$59
Mallinckrodt Hospital Products Inc.
$44
Merck Sharp & Dohme LLC
$43
QOL Medical, LLC
$39
PFIZER INC.
$34
Phathom Pharmaceuticals, Inc.
$33
Fresenius Kabi USA, LLC
$31
Regeneron Healthcare Solutions, Inc.
$30
IRONWOOD PHARMACEUTICALS, INC
$29
Boston Scientific Corporation
$24
Boehringer Ingelheim Pharmaceuticals, Inc.
$22
AIMMUNE THERAPEUTICS, INC.
$18
Amgen Inc.
$18
Intercept Pharmaceuticals, Inc.
$17
Ipsen Biopharmaceuticals, Inc
$17
CapsoVision, Inc.
$16
Organon Llc
$15
Top 3 companies account for 49.1% of 2024 payments
All-time payments by company (2018-2024) ›
Allergan Inc.
$35,583
Synergy Pharmaceuticals Inc
$9,860
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$7,537
ABBVIE INC.
$876
Gilead Sciences, Inc.
$618
Takeda Pharmaceuticals U.S.A., Inc.
$442
AbbVie Inc.
$403
AbbVie, Inc.
$399
Romark Laboratories, LC
$300
Olympus America Inc.
$255
Ironwood Pharmaceuticals, Inc
$251
Celgene Corporation
$198
GENZYME CORPORATION
$183
QOL Medical, LLC
$183
PFIZER INC.
$172
Janssen Biotech, Inc.
$122
Medtronic USA, Inc.
$118
Ardelyx, Inc.
$114
Merck Sharp & Dohme LLC
$105
Lilly USA, LLC
$98
INTERCEPT PHARMACEUTICALS, INC.
$92
Regeneron Healthcare Solutions, Inc.
$85
Nestle HealthCare Nutrition Inc.
$82
Amgen Inc.
$78
Organon LLC
$70
NESTLE HEALTHCARE NUTRITION INC.
$58
Merck Sharp & Dohme Corporation
$51
Evoke Pharma, Inc.
$48
Boehringer Ingelheim Pharmaceuticals, Inc.
$47
Mallinckrodt Hospital Products Inc.
$44
IRONWOOD PHARMACEUTICALS, INC
$44
Medtronic, Inc.
$36
Phathom Pharmaceuticals, Inc.
$33
Fresenius Kabi USA, LLC
$31
Boston Scientific Corporation
$24
Daiichi Sankyo Inc.
$23
Shionogi Inc
$23
Alnylam Pharmaceuticals Inc.
$20
AIMMUNE THERAPEUTICS, INC.
$18
Shield Therapeutics Inc
$17
Intercept Pharmaceuticals, Inc.
$17
Ipsen Biopharmaceuticals, Inc
$17
CapsoVision, Inc.
$16
Organon Llc
$15
Enterra Medical, Inc.
$15
BOSTON SCIENTIFIC CORPORATION
$14
RedHill Biopharma Inc.
$14
Dova Pharmaceuticals
$12
Top 3 companies account for 90.0% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AMJEVITA · APRISO · Alinia Tablets 500mg 30 count bottle · Amitiza · CREON · CYCLOSET · CYLTEZO · CapsoCam Plus · Creon · DIFICID · DUPIXENT · Dexilant · Doptelet · ENTYVIO · EOHILIA · Entyvio · Epclusa · GENERAL THERAPIES · GIMOTI · GIVLAARI · HUMIRA · Humira · IBSRELA · IDACIO · INFLECTRA · INJECTAFER · INTERSTIM · IQIRVO · LINQ II · LINZESS · Linzess · MAVYRET · MOTEGRITY · Mavyret · Motegrity · OCALIVA · OMVOH · Olympus EndoTherapy Accessories · Olympus GI Accessories · REMICADE · RENFLEXIS · RINVOQ · SKYRIZI · STELARA · SUCRAID · Single Use Electrosurgical Knife KD-655 · Sucraid · Symproic · TERLIVAZ · TREMFYA · TRULANCE · Talicia · Trulance · UCERIS · VELSIPITY · VIBERZI · VOQUEZNA · VOWST · Vemlidy · XELJANZ · XIFAXAN · XIFIXAN · ZENPEP · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (89%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in gastroenterology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 7% for gastroenterology in IL.
Geographic Context
Gastroenterologists within 10 mi
349
Per 100K population
6.7
County median income
$81,797
Nearest hospital
INGALLS MEMORIAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bierman is a clinical cardiology specialist, with above-average Medicare volume (top 5% in IL), with speaking/promotional industry engagement in the top 7% of IL peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bierman experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Bierman performed 462 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bierman receive payments from pharmaceutical companies?
Yes. Dr. Bierman received a total of $58,864 from 48 companies across 516 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bierman's costs compare to other gastroenterologists in Harvey?
Dr. Bierman's average Medicare payment per service is $81. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bierman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Harvey
Browse gastroenterologists in Harvey ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in IL
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in IL
Which IL gastroenterologists receive the most from drug and device companies.
By company
Allergan Inc. Payments to Doctors
See all physicians who received payments from Allergan Inc.
By company
Synergy Pharmaceuticals Inc Payments to Doctors
See all physicians who received payments from Synergy Pharmaceuticals Inc.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology